ORION BIOTECH OPPORTUNTES CO's ticker is ORIAW and the CUSIP is G6780C117. A total of 28 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $8,894 | -47.3% | 111,314 | 0.0% | 0.01% | +33.3% |
| Q4 2022 | $16,886 | -15.6% | 111,314 | 0.0% | 0.01% | +50.0% |
| Q3 2022 | $20,000 | +17.6% | 111,314 | 0.0% | 0.01% | +50.0% |
| Q2 2022 | $17,000 | -58.5% | 111,314 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $41,000 | -64.3% | 111,314 | -7.2% | 0.01% | -45.5% |
| Q4 2021 | $115,000 | +9.5% | 120,000 | 0.0% | 0.01% | +37.5% |
| Q3 2021 | $105,000 | – | 120,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ANGELO GORDON & CO., L.P. | 60,000 | $584,000 | 0.06% |
| Empery Asset Management, LP | 39,700 | $6,000 | 0.03% |
| Radcliffe Capital Management, L.P. | 80,001 | $779,000 | 0.02% |
| Anson Funds Management LP | 15,000 | $146,000 | 0.01% |
| Segantii Capital Management Ltd | 30,000 | $292,000 | 0.01% |
| Arena Capital Advisors, LLC- CA | 111,314 | $17,000 | 0.00% |
| 683 Capital Management, LLC | 239,800 | $36,000 | 0.00% |
| Atalaya Capital Management LP | 100,000 | $15,000 | 0.00% |
| MMCAP International Inc. SPC | 159,802 | $24,000 | 0.00% |
| MARSHALL WACE, LLP | 54,995 | $536,000 | 0.00% |